» Articles » PMID: 37426810

Exploring the Mechanisms Under Zuogui Pill's Treatment of Ischemic Stroke Through Network Pharmacology and Experimental Verification

Overview
Journal Front Pharmacol
Date 2023 Jul 10
PMID 37426810
Authors
Affiliations
Soon will be listed here.
Abstract

Due to its high mortality, incidence and disability rates, ischemic stroke poses heavy economic burdens to families and society. Zuogui Pill (ZGP) is a classic Chinese medicine for tonifying the kidney, which is effective for the recovery of neurological function after ischemic stroke. However, Zuogui Pill has not been evaluated for its potential effects on ischemic strokes. Using network pharmacology, the research aimed to explore the mechanisms of Zuogui Pill on ischemic stroke, which were further validated in SH-SY5Y cells injured by oxygen and glucose deprivation/reperfusion (OGD/R). Network analysis of Zuogui Pill identified 86 active ingredients and 107 compound-related targets correlated with ischemic stroke. Additionally, 11 core active compounds were obtained, such as Quercetin, beta sitosterol, and stigmasterol. Most of the compounds have been proven to have pharmacological activities. Based on pathway enrichment studies, Zuogui Pill may exert neuroprotection through MAPK signaling, PI3K-Akt signaling and apoptosis, as well as enhance neurite outgrowth and axonal regeneration effect via mTOR signaling, p53 signaling and Wnt signaling pathways. experiment, the viability of ischemic neuron treated with Zuogui Pill was increased, and the ability of neurite outgrowth was significantly improved. Western blot assays shown that the pro-neurite outgrowth effect of Zuogui Pill on ischemic stroke may be relate to PTEN/mTOR signal pathway. The results of the study provided new insights into Zuogui Pill's molecular mechanism in treatment of ischemic stroke, as well as clinical references for its use.

References
1.
Garcia A, Udeh A, Kalahasty K, Hackam A . A growing field: The regulation of axonal regeneration by Wnt signaling. Neural Regen Res. 2018; 13(1):43-52. PMC: 5840987. DOI: 10.4103/1673-5374.224359. View

2.
Zhu M, Liu M, Guo Q, Zhu C, Guo J . Prolonged DADLE exposure epigenetically promotes Bcl-2 expression and elicits neuroprotection in primary rat cortical neurons via the PI3K/Akt/NF-κB pathway. Acta Pharmacol Sin. 2018; 39(10):1582-1589. PMC: 6289365. DOI: 10.1038/aps.2018.7. View

3.
Guo C, Wang W, Liao Y, Zhao C, Yin Y, Yao M . Effect and Mechanisms of Quercetin for Experimental Focal Cerebral Ischemia: A Systematic Review and Meta-Analysis. Oxid Med Cell Longev. 2022; 2022:9749461. PMC: 8896934. DOI: 10.1155/2022/9749461. View

4.
Bei F, Lee H, Liu X, Gunner G, Jin H, Ma L . Restoration of Visual Function by Enhancing Conduction in Regenerated Axons. Cell. 2016; 164(1-2):219-232. PMC: 4863988. DOI: 10.1016/j.cell.2015.11.036. View

5.
Yan T, He B, Xu M, Wu B, Xiao F, Bi K . Kaempferide prevents cognitive decline via attenuation of oxidative stress and enhancement of brain-derived neurotrophic factor/tropomyosin receptor kinase B/cAMP response element-binding signaling pathway. Phytother Res. 2019; 33(4):1065-1073. DOI: 10.1002/ptr.6300. View